TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT05077904: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Pr

Sponsor: UCB Biopharma SRL · Phase: PHASE3 · Area: CNS_NEUROLOGY · Target Enrollment: 350 pts

Competing Trials Overlap

11 Active Trials

Excess Burn Exposure

$661,152

Rescue Site Savings

+$440,768

Unlock Full NCT05077904 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05077904 Rescue Dossier →